CARBOPLATIN , JNJ-42756493, JNJ-63723283, CISPLATIN , JNJ-42756493, JNJ-63723283, JNJ-42756493
42756493BLC2002
Phase 2 small_molecule active
Quick answer
CARBOPLATIN , JNJ-42756493, JNJ-63723283, CISPLATIN , JNJ-42756493, JNJ-63723283, JNJ-42756493 for Metastatic or Locally Advanced Urothelial Cancer is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Metastatic or Locally Advanced Urothelial Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active